Chemical Component Summary | |
|---|---|
| Name | NARINGENIN |
| Identifiers | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one |
| Formula | C15 H12 O5 |
| Molecular Weight | 272.253 |
| Type | NON-POLYMER |
| Isomeric SMILES | c1cc(ccc1[C@@H]2CC(=O)c3c(cc(cc3O2)O)O)O |
| InChI | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1 |
| InChIKey | FTVWIRXFELQLPI-ZDUSSCGKSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 32 |
| Chiral Atom Count | 1 |
| Bond Count | 34 |
| Aromatic Bond Count | 12 |
Drug Info: DrugBank
| DrugBank ID | DB03467 |
|---|---|
| Name | Naringenin |
| Groups | experimental |
| Synonyms | Naringenin |
| Categories |
|
| CAS number | 480-41-1 |
Drug Targets
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| HTH-type transcriptional regulator TtgR | MVRRTKEEAQETRAQIIEAAERAFYKRGVARTTLADIAELAGVTRGAIYW... | unknown | |
| Estrogen receptor alpha | MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPA... | unknown | |
| Aldo-keto reductase family 1 member C1 | MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHID... | unknown | antagonist |
| Cytochrome P450 1B1 | MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSA... | unknown | |
| KAT8 regulatory NSL complex subunit 3 | MAHRGGERDFQTSARRMGTSLLFQLSVHERELDLVFLDHSYAKPWSAHPD... | unknown | |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL9352 |
| PubChem | 439246 |
| ChEMBL | CHEMBL9352 |
| ChEBI | CHEBI:17846 |
| CCDC/CSD | DOLRIF, AYUJAH, OQEDOG |
| COD | 2201847 |
